Commerce Bank’s Maravai LifeSciences MRVI Stock Holding History

Commerce Bank’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,446	Closed	-$240K	–	1156
2022 Q2	$240K	Hold	8,446	–	–	﹤0.01%	1036
2022 Q1	$298K	Sell	8,446 -139	-2%	-$4.66K	﹤0.01%	1006
2021 Q4	$359K	Buy	8,585 +3,314	+63%	+$134K	﹤0.01%	962
2021 Q3	$259K	Buy	+5,271	New	+$257K	﹤0.01%	1044

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Commerce Bank's MRVI Position: Q3 2022 in Review

Commerce Bank sold out of Maravai LifeSciences (MRVI) in Q3 2022, closing a stake of 8,446 shares — an estimated $240K sold.

Commerce Bank first reported a position in MRVI in Q3 2021 and held it in 4 quarters. The position peaked at $359K in Q4 2021. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2022.

Commerce Bank reported no remaining Maravai LifeSciences position as of Q3 2022 after selling out during the quarter.
Commerce Bank sold 8,446 Maravai LifeSciences shares in Q3 2022, an estimated $240K.
Commerce Bank first reported a position in Maravai LifeSciences in Q3 2021 and held it in 4 quarters.
Commerce Bank's Maravai LifeSciences position peaked at $359K in Q4 2021.
202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2022.

Based on Commerce Bank's 13F filing for Q3 2022, filed 4 Nov 2022.